Modulating the Cellular Immune Response of Oligonucleotides by Brush Polymer-Assisted Compaction.

about

Modulating the Cellular Immune Response of Oligonucleotides by Brush Polymer-Assisted Compaction.

Item

http://www.wikidata.org/entity/Q47937462

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@en

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@nl

type

Item

label

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@en

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@nl

prefLabel

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@en

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@nl

P1476

Modulating the Cellular Immune ...... h Polymer-Assisted Compaction.

@en

P2093

Dali Wang

http://www.w3.org/2001/XMLSchema#string

Ke Zhang

http://www.w3.org/2001/XMLSchema#string

Michelle Corley

http://www.w3.org/2001/XMLSchema#string

Xiaoying Chen

http://www.w3.org/2001/XMLSchema#string

Xueguang Lu

http://www.w3.org/2001/XMLSchema#string

Xueyan Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

A Toll-like receptor recognizes bacterial DNA

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Toll-like receptor signalling

Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

Impact of carbon nanotubes and graphene on immune cells

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

Pathways of clathrin-independent endocytosis

Nivolumab in previously untreated melanoma without BRAF mutation

P31

scholarly article

P356

10.1002/SMLL.201701432

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fei Jia

Xuyu Tan

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696590

http://www.w3.org/2001/XMLSchema#string